Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jazz Pharmaceuticals (JAZZ)
NASDAQ:JAZZ
Holding JAZZ?
Track your performance easily
Jazz Pharmaceuticals (JAZZ) Ownership Overview
3.27% Insiders
26.30% Mutual Funds
31.77% Other Institutional Investors
27.36% ETFs
11.29% Public Companies and Individual Investors
The ownership structure of Jazz Pharmaceuticals (JAZZ) stock is a mix of institutional, retail, and individual investors. Approximately 85.44% of the company’s stock is owned by Institutional Investors, 3.27% is owned by Insiders, and 11.29% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Sep 11, 2024 | Mary Elizabeth Henderson Svp Tech. Op | xxxxxxxxxxxxx | $152703 |
| May 07, 2024 | Neena M Patil Evp & Clo | xxxxxxxxxxxxx | $548250 |
| Mar 08, 2024 | Patricia Carr Svp & Cao | xxxxxxxxxxxxx | $438448 |
| Mar 05, 2024 | Philip L Johnson Evp & Chief Financial Officer | xxxxxxxxxxxxx | $1435800 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $668 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $88125 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $267941 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $2343286 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,626,096 | Institution | 9.31% | 670,855,687 | |
| 5,433,701 | Institution | 8.99% | 647,914,507 | |
| 5,353,307 | Institution | 8.86% | 638,328,327 | |
| 2,126,190 | Institution | 3.52% | 253,526,896 | |
| 1,999,090 | Institution | 3.31% | 238,371,492 | |
| 1,305,560 | Institution | 2.16% | 155,674,974 | |
| 1,274,248 | Institution | 2.11% | 151,941,332 | |
| 1,176,106 | Insider | 1.95% | 140,238,879 | |
| 1,046,410 | Institution | 1.73% | 124,773,928 | |
| 855,847 | Institution | 1.42% | 102,051,196 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,353,307 | Institution | 8.86% | 638,328,327 | |
| 1,999,090 | Institution | 3.31% | 238,371,492 | |
| 855,847 | Institution | 1.42% | 102,051,196 | |
| 658,517 | Institution | 1.09% | 78,521,567 | |
| 625,591 | Institution | 1.03% | 74,595,471 | |
| 597,840 | Institution | 0.99% | 71,286,442 | |
| 410,082 | Institution | 0.68% | 48,898,178 | |
| 375,294 | Institution | 0.62% | 44,750,057 | |
| 326,269 | Institution | 0.54% | 38,904,316 | |
| 317,978 | Institution | 0.53% | 37,915,697 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,955,920 | Institution | 3.24% | 270,816,683 | |
| 2,101,764 | Institution | 3.48% | 245,528,070 | |
| 1,964,186 | Institution | 3.25% | 234,209,539 | |
| 1,834,171 | Institution | 3.03% | 201,813,835 | |
| 1,471,310 | Institution | 2.43% | 161,888,239 | |
| 994,026 | Institution | 1.64% | 109,372,681 | |
| 918,717 | Institution | 1.52% | 101,086,432 | |
| 494,234 | Institution | 0.82% | 58,932,462 | |
| 247,900 | Institution | 0.41% | 28,959,678 | |
| 238,818 | Institution | 0.40% | 28,476,658 |
FAQ
Who Owns Jazz Pharmaceuticals (JAZZ)?
According to the latest TipRanks data, approximately 31.77% of the company's stock is held by institutional investors, 3.27% is held by insiders, and 11.29% is held by retail investors.
What percentage of Jazz Pharmaceuticals (JAZZ) stock is held by institutional investors?
According to the latest TipRanks data, approximately 31.77% of Jazz Pharmaceuticals (JAZZ) stock is held by institutional investors.
What percentage of Jazz Pharmaceuticals (JAZZ) stock is held by retail investors?
According to the latest TipRanks data, approximately 11.29% of Jazz Pharmaceuticals (JAZZ) stock is held by retail investors.
Who owns the most shares of Jazz Pharmaceuticals (JAZZ)?
Vanguard owns the most shares of Jazz Pharmaceuticals (JAZZ).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.